NextCure Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

NextCure Stock Summary

NextCure competes with CytomX Therapeutics, Spero Therapeutics, Instil Bio, Assembly Biosciences, and Nuvation Bio. NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland. Nextcure operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.

NextCure Key Financial Ratios

NextCure Key Balance Sheet Accounts

NextCure Key Income Statement Accounts

NextCure Key Cash Accounts

NextCure Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NextCure's current stock value. Our valuation model uses many indicators to compare NextCure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NextCure competition to find correlations between indicators driving NextCure's intrinsic value. More Info.NextCure is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, NextCure's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NextCure's earnings, one of the primary drivers of an investment's value.

NextCure Systematic Risk

Today, most investors in NextCure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NextCure's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of NextCure growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of NextCure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NextCure. We use our internally-developed statistical techniques to arrive at the intrinsic value of NextCure based on widely used predictive technical indicators. In general, we focus on analyzing NextCure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NextCure's daily price indicators and compare them against related drivers.

When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.